Introduction to Melanoma: Risks, Development, and Treatment
DOI:
https://doi.org/10.47611/jsrhs.v13i4.8036Keywords:
melanoma, biology, cancer, oncologyAbstract
This paper provides a general introductory overview to malignant melanoma, one of the most common, yet deadly skin cancers in the world. The two main categories of melanoma, cutaneous and non-cutaneous, have differences in affected tissues, risk factors, and driving mutations. The carcinogenesis of melanoma is driven by pathogenic dysregulation in the MAPK pathway, p53 protein, and cell cycle checkpoints. There exist four main treatment approaches up to date: surgical resection, chemotherapy, targeted therapy and immunotherapy. Although recent advancements in immunotherapies have improved treatment options immensely, additional research is needed to develop more effective strategies to lower the mortality rate further.
Downloads
References or Bibliography
Davis, Lauren E et al. “Current state of melanoma diagnosis and treatment.” Cancer biology & therapy vol. 20,11 (2019): 1366-1379. doi:10.1080/15384047.2019.1640032.
de Gooijer, Mark C et al. “The G2 checkpoint-a node-based molecular switch.” FEBS open bio vol. 7,4 439-455. 4 Mar. 2017, doi:10.1002/2211-5463.12206.
Lazova, Rossitza, and John M Pawelek. “Why do melanomas get so dark?.” Experimental dermatology vol. 18,11 (2009): 934-8. doi:10.1111/j.1600-0625.2009.00933.x.
“Melanoma of the Skin - Cancer Stat Facts.” SEER, National Cancer Institute, www.seer.cancer.gov/statfacts/html/melan.html.
Mogensen, Mette, and Gregor Be Jemec. “The potential carcinogenic risk of tanning beds: clinical guidelines and patient safety advice.” Cancer management and research vol. 2 277-82. 28 Oct. 2010, doi:10.2147/CMR.S7403.
Morris, E J et al. “Cyclin-dependent kinases and P53 pathways are activated independently and mediate Bax activation in neurons after DNA damage.” The Journal of neuroscience : the official journal of the Society for Neuroscience vol. 21,14 (2001): 5017-26. doi:10.1523/JNEUROSCI.21-14-05017.2001.
Nasti, Tahseen H, and Laura Timares. “MC1R, eumelanin and pheomelanin: their role in determining the susceptibility to skin cancer.” Photochemistry and photobiology vol. 91,1 (2015): 188-200. doi:10.1111/php.12335.
Raimondi, Sara et al. “Melanoma Epidemiology and Sun Exposure.” Acta dermato-venereologica vol. 100,11 (2020): adv00136. doi:10.2340/00015555-3491.
“Skin Cancer Statistics: World Cancer Research Fund International.” WCRF International, World Cancer Research Fund International, 14 Apr. 2022, www.wcrf.org/cancer-trends/skin-cancer-statistics.
Teixido, Cristina et al. “Molecular Markers and Targets in Melanoma.” Cells vol. 10,9 2320. 5 Sep. 2021, doi:10.3390/cells10092320.
“UV Radiation.” UV Radiation - Skin Cancer Statistics and Issues, Cancer Council Australia, 15 June 2020, www.wiki.cancer.org.au/skincancerstats/UV_radiation#UV_Index.
Vergara, Ismael A et al. “Genetic drivers of non-cutaneous melanomas: Challenges and opportunities in a heterogeneous landscape.” Experimental dermatology vol. 31,1 (2022): 13-30. doi:10.1111/exd.14287.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Grace Yu
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
